Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Stock-based Compensation

v3.6.0.2
Note 5 - Stock-based Compensation
9 Months Ended
Jan. 01, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
N
ote
5
– Stock-based Compensation
 
The Company has
two
incentive stock plans, the
2006
Omnibus Incentive Plan (the
“2006
Plan”) and the
2014
Omnibus Equity Compensation Plan (the
“2014
Plan”). As a result of the approval of the
2014
Plan by the Company’s stockholders at the Company’s
2014
annual meeting, grants
may
no longer be issued under the
2006
Plan.
 
The Company believes that awards of long-term, equity-based incentive compensation will attract and retain directors, officers and employees of the Company and will encourage these individuals to contribute to the successful performance of the Company, which will lead to the achievement of the Company’s overall goal of increasing stockholder value. Awards granted under the
2014
Plan
may
be in the form of incentive stock options, non-qualified stock options, shares of restricted or unrestricted stock, stock units, stock appreciation rights or other stock-based awards. Awards
may
be granted subject to the achievement of performance goals or other conditions, and certain awards
may
be payable in stock or cash, or a combination of the
two.
The
2014
Plan is administered by the Compensation Committee of the Company’s Board of Directors (the “Board”), which selects eligible employees, non-employee directors and other individuals to participate in the
2014
Plan and determines the type, amount, duration and other terms of individual awards. Grants under the
2014
Plan are settled primarily through the issuance of new shares of the Company’s common stock,
814,000
shares of which were available for future issuance under the
2014
Plan as of
January
1,
2017.
 
Stock-based compensation expense is calculated according to FASB ASC Topic
718,
Compensation – Stock Compensation
, which requires stock-based compensation expense to be accounted for using a fair-value-based measurement. The Company recorded stock-based compensation expense of
$149,000
and
$212,000
for the
three
-month periods ended
January
1,
2017
and
December
27,
2015,
respectively, and recorded
$456,000
and
$691,000
for the
nine
-month periods ended
January
1,
2017
and
December
27,
2015,
respectively.
The Company classifies the compensation expense associated with stock-based awards granted to individuals in the same classifications as the cash compensation paid to those same individuals.
No
stock-based compensation costs have been capitalized as part of the cost of an asset as of
January
1,
2017.
 
Stock Options:
The following table represents stock option activity for
the
nine
-month periods ended
January
1,
2017
and
December
27,
2015
:
 
 
 
Nine-Month Period Ended
 
 
Nine-Month Period Ended
 
 
 
January 1, 2017
 
 
December 27, 2015
 
 
 
Weighted-
 
 
 
 
 
 
Weighted-
 
 
 
 
 
 
 
Average
 
 
Number of
 
 
Average
 
 
Number of
 
 
 
Exercise
 
 
Options
 
 
Exercise
 
 
Options
 
 
 
Price
 
 
Outstanding
 
 
Price
 
 
Outstanding
 
Outstanding at Beginning of Period
  $
7.64
     
305,000
    $
6.83
     
330,000
 
Granted
   
9.60
     
120,000
     
8.38
     
110,000
 
Exercised
   
7.67
     
(102,500
)    
6.30
     
(55,000
)
Outstanding at End of Period
   
8.35
     
322,500
     
7.35
     
385,000
 
Exercisable at End of Period
   
7.33
     
147,500
     
6.52
     
192,500
 
 
As of
January
1,
2017,
the intrinsic value of both the outstanding and exercisable stock options was
$
94,000
.
The intrinsic value of the stock options exercised during the
three
and
nine
-month periods ended
January
1,
2017
was
$45,000
and
$214,000,
respectively. The Company did
not
receive any cash from the exercise of stock options during the
three
and
nine
-month periods ended
January
1,
2017
and
December
27,
2015.
Upon the exercise of stock options, participants
may
choose to surrender to the Company those shares from the option exercise necessary to satisfy the exercise amount and their income tax withholding obligations that arise from the option exercise. The effect on the cash flow of the Company from these “cashless” option exercises is that the Company remits cash on behalf of the participant to satisfy his or her income tax withholding obligations. The Company used cash to remit the required income tax withholding amounts from “cashless” option exercises of
$14,000
and
$75,000
during the
three
and
nine
-month periods ended
January
1,
2017,
respectively, and
$25,000
and
$37,000
during the
three
and
nine
-month periods ended
December
27,
2015,
respectively.
 
To determine the estimated fair value of stock options granted, the Company uses the Black-Scholes-Merton valuation formula, which is a closed-form model that uses an equation to estimate fair value. The following table sets forth the assumptions used to determine the fair value of the non-qualified stock options which were awarded to certain employees during the
nine
-month periods ended
January
1,
2017
and
December
27,
2015,
which options vest over a
two
-year period, assuming continued service.
 
 
 
Nine-Month Periods Ended
 
 
 
January 1, 2017
 
 
December 27, 2015
 
Options issued
   
120,000
     
110,000
 
Grant date
   
June 8, 2016
     
June 12, 2015
 
Dividend yield
   
3.33
%    
3.82
%
Expected volatility
   
20.00
%    
20.00
%
Risk free interest rate
   
0.93
%    
1.12
%
Contractual term (years)
   
10.00
     
10.00
 
Expected term (years)
   
3.00
     
3.00
 
Forfeiture rate
   
5.00
%    
5.00
%
Exercise price (grant-date closing price) per option
  $
9.60
    $
8.38
 
Fair value per option
  $
0.94
    $
0.77
 
 
For the
three
-month periods ended
January
1,
2017
and
December
27,
2015,
the Company recognized compensation expense associated with stock options as follows (in thousands):
 
 
 
Three-Month Period Ended January 1, 2017
 
 
Three-Month Period Ended December 27, 2015
 
 
 
Cost of
 
 
Marketing &
 
 
 
 
 
 
Cost of
 
 
Marketing &
 
 
 
 
 
 
 
Products
 
 
Administrative
 
 
Total
 
 
Products
 
 
Administrative
 
 
Total
 
Options Granted in Fiscal Year
 
Sold
 
 
Expenses
 
 
Expense
 
 
Sold
 
 
Expenses
 
 
Expense
 
2015
  $
-
    $
-
    $
-
    $
12
    $
10
    $
22
 
2016
   
5
     
5
     
10
     
5
     
4
     
9
 
2017
   
8
     
5
     
13
     
-
     
-
     
-
 
                                                 
Total stock option compensation
  $
13
    $
10
    $
23
    $
17
    $
14
    $
31
 
 
For the
nine
-month periods ended
January
1,
2017
and
December
27,
2015,
the Company recognized compensation expense associated with stock options as follows (in thousands):
 
 
 
Nine-Month Period Ended January 1, 2017
 
 
Nine-Month Period Ended December 27, 2015
 
 
 
Cost of
 
 
Marketing &
 
 
 
 
 
 
Cost of
 
 
Marketing &
 
 
 
 
 
 
 
Products
 
 
Administrative
 
 
Total
 
 
Products
 
 
Administrative
 
 
Total
 
Options Granted in Fiscal Year
 
Sold
 
 
Expenses
 
 
Expense
 
 
Sold
 
 
Expenses
 
 
Expense
 
2014
  $
-
    $
-
    $
-
    $
7
    $
7
    $
14
 
2015
   
14
     
12
     
26
     
40
     
34
     
74
 
2016
   
17
     
15
     
32
     
11
     
9
     
20
 
2017
   
18
     
12
     
30
     
-
     
-
     
-
 
                                                 
Total stock option compensation
  $
49
    $
39
    $
88
    $
58
    $
50
    $
108
 
 
As of
January
1,
2017,
total unrecognized stock option compensation expense amounted to
$103,000,
which will be recognized as the underlying stock options vest over a weighted-average period of
9.3
months. The amount of future stock option compensation expense could be affected by any future stock option grants and by the separation from the Company of any individual who has received stock options that are unvested as of such individual’s separation date.
 
Non-vested Stock
Granted to Non-Employee Directors:
The Board granted the following shares of non-vested stock to the Company’s non-employee directors:
 
Number of Shares
   
Fair Value per Share
 
Three-Month Period Ended
28,000      
$10.08
 
October 2, 2016
28,000      
$8.20
 
September 27, 2015
28,000      
$7.97
 
September 28, 2014
28,000      
$6.67
 
September 29, 2013
 
These shares vest over a
two
-year period, assuming continued service. The fair value of the non-vested stock granted to the Company’s non-employee directors was based on the closing price of the Company’s common stock on the date of each grant. In
August
2016,
28,000
shares vested that had been granted to the Company’s non-employee directors, with such shares having an aggregate value of
$281,000.
 
Non-vested Stock
Granted to Employees:
During the
three
-month period ended
June
27,
2010,
the Board awarded
345,000
shares of non-vested stock to certain employees in a series of grants, each of which was to vest only if (i) the closing price of the Company’s common stock was at or above certain target levels for any
ten
trading days out of any period of
30
consecutive trading days and (ii) the respective employees remained employed through
July
29,
2015.
The Company, with the assistance of an independent
third
party, determined that the aggregate grant date fair value of the awards amounted to
$1.2
million.
 
With the closing price conditions having been met for these awards, the Board at various times approved amendments to provide for the immediate vesting of all or a portion of several of the grants. The vesting of these awards was accelerated in order to maximize the deductibility of the associated compensation expense by the Company for income tax purposes.
During the
three
-month period ended
September
27,
2015,
the remaining
240,000
of these shares vested, with such shares having an aggregate value of
$1.9
million. Each of the individuals holding shares that vested surrendered to the Company the number of shares necessary to satisfy the income tax withholding obligations that arose from the vesting of the shares, and the Company remitted
$948,000
to the appropriate taxing authorities on behalf of such individuals.
 
Performance Bonus Plan:
  The Company maintains a performance bonus plan for certain executive officers that provides for awards of shares of common stock in the event that the aggregate average market value of the common stock during the relevant fiscal year, plus the amount of cash dividends paid in respect of the common stock during such period, increases.
These individuals
may
instead be awarded cash, if and to the extent that insufficient shares of common stock are available for issuance from all shareholder-approved, equity-based plans or programs of the Company in effect. The performance bonus plan also imposes individual limits on awards and
provides that shares of common stock that
may
be awarded will vest over a
two
-year period. Compensation expense associated with performance bonus plan awards are recognized over a
three
-year period – the fiscal year in which the award is earned, plus the
two
-year vesting period.
 
In connection with the performance bonus plan, the Company, in respect of fiscal year
2016,
awarded
41,205
shares of common stock with a fair value of
$7.865
per share during the
three
-month period ended
July
3,
2016.
In connection with these awards, the Company recognized compensation expense of
$108,000
during fiscal year
2016,
and will recognize, on a straight-line basis,
$
108,000
in compensation expense during each of fiscal years
2017
and
2018.
 
In connection with the performance bonus plan, the Company, in respect of fiscal year
2015,
awarded
58,532
shares of common stock with a fair value of
$7.18
per share during the
three
-month period ended
June
28,
2015.
In connection with these awards, the Company recognized compensation expense of
$
140,000
during each of fiscal years
2015
and
2016,
and will recognize, on a straight-line basis,
$140,000
in compensation expense during fiscal year
2017.
 
In connection with the performance bonus plan, the Company, in respect of fiscal year
2014,
awarded
188,232
shares of common stock with a fair value of
$5.65
per share during the
three
-month period ended
June
29,
2014.
In connection with these awards, the Company recognized compensation expense of
$
354,000
during each of fiscal years
2014,
2015
and
2016.
During the
three
-month period ended
June
28,
2015,
94,116
of these shares vested, with such shares having an aggregate value of
$735,000.
Each of the individuals holding shares that vested surrendered to the Company the number of shares necessary to satisfy the income tax withholding obligations that arose from the vesting of the shares, and the Company remitted
$360,000
to the appropriate taxing authorities on behalf of such individuals.
 
For the
three
-month periods ended
January
1,
2017
and
December
27,
2015,
the Company recognized compensation expense associated with stock grants, which is included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income, as follows (in thousands):
 
 
 
Three-Month Period Ended January 1, 2017
 
 
Three-Month Period Ended December 27, 2015
 
 
 
 
 
 
 
Non-employee
 
 
Total
 
 
 
 
 
 
Non-employee
 
 
Total
 
Stock Granted in Fiscal Year
 
Employees
 
 
Directors
 
 
Expense
 
 
Employees
 
 
Directors
 
 
Expense
 
2015
  $
-
    $
-
    $
-
    $
89
    $
28
    $
117
 
2016
   
35
     
29
     
64
     
35
     
29
     
64
 
2017
   
27
     
35
     
62
     
-
     
-
     
-
 
                                                 
Total stock grant compensation
  $
62
    $
64
    $
126
    $
124
    $
57
    $
181
 
 
 
For the
nine
-month periods ended
January
1,
2017
and
December
27,
2015,
the Company recognized compensation expense associated with stock grants, which is included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income, as follows (in thousands):
 
 
 
Nine-Month Period Ended January 1, 2017
 
 
Nine-Month Period Ended December 27, 2015
 
 
 
 
 
 
 
Non-employee
 
 
Total
 
 
 
 
 
 
Non-employee
 
 
Total
 
Stock Granted in Fiscal Year
 
Employees
 
 
Directors
 
 
Expense
 
 
Employees
 
 
Directors
 
 
Expense
 
2011
  $
-
    $
-
    $
-
    $
48
    $
-
    $
48
 
2014
   
-
     
-
     
-
     
-
     
31
     
31
 
2015
   
-
     
37
     
37
     
267
     
84
     
351
 
2016
   
105
     
86
     
191
     
105
     
48
     
153
 
2017
   
81
     
59
     
140
     
-
     
-
     
-
 
                                                 
Total stock grant compensation
  $
186
    $
182
    $
368
    $
420
    $
163
    $
583
 
 
As of
January
1,
2017,
total unrecognized compensation expense related to the Company’s non-vested stock grants amounted to
$460,000,
which will be recognized over the respective vesting terms associated with each block of non-vested stock indicated above, such grants having an aggregate weighted-average vesting term of
8.2
months. The amount of future compensation expense related to the Company’s non-vested stock grants could be affected by any future non-vested stock grants and by the separation from the Company of any individual who has non-vested stock grants as of such individual’s separation date.